New Zealand markets open in 3 hours 30 minutes

Novo Nordisk A/S (NVO)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
107.080.00 (0.00%)
As of 12:29PM EST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in DKK. All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
134,605,000
126,946,000
122,021,000
111,831,000
111,696,000
Cost of revenue
23,036,000
20,932,000
20,088,000
17,617,000
17,632,000
Gross profit
111,569,000
106,014,000
101,933,000
94,214,000
94,064,000
Operating expenses
Research development
16,623,000
15,462,000
14,220,000
14,805,000
14,014,000
Selling general and administrative
39,200,000
36,886,000
35,830,000
33,313,000
32,124,000
Total operating expenses
55,381,000
51,888,000
49,450,000
46,966,000
45,097,000
Operating income or loss
56,188,000
54,126,000
52,483,000
47,248,000
48,967,000
Interest expense
-30,000
390,000
220,000
85,000
90,000
Total other income/expenses net
-
-793,000
-3,494,000
473,000
-198,000
Income before tax
57,969,000
53,130,000
48,553,000
47,615,000
48,680,000
Income tax expense
11,786,000
10,992,000
9,602,000
8,987,000
10,550,000
Income from continuing operations
46,183,000
42,138,000
38,951,000
38,628,000
38,130,000
Net income
46,183,000
42,138,000
38,951,000
38,628,000
38,130,000
Net income available to common shareholders
46,183,000
42,138,000
38,951,000
38,628,000
38,130,000
Basic EPS
-
18.05
16.41
15.96
15.42
Diluted EPS
-
18.01
16.38
15.93
15.39
Basic average shares
-
2,333,900
2,374,299
2,419,603
2,473,218
Diluted average shares
-
2,340,000
2,378,658
2,424,417
2,478,093
EBITDA
-
59,273,000
54,434,000
51,625,000
51,952,000